
In the Spotlight
Finding new ways to treat glioblastoma
In January 2022, Hans-Georg Wirsching and his research group started their project, “A phase Ib/II randomized drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma (GLUGLIO)”, which […]